tiprankstipranks
Trending News
More News >
T2 Biosystems (TTOO)
OTHER OTC:TTOO
US Market

T2 Biosystems (TTOO) Ratios

Compare
2,242 Followers

T2 Biosystems Ratios

TTOO's free cash flow for Q3 2024 was $-1.07. For the 2024 fiscal year, TTOO's free cash flow was decreased by $ and operating cash flow was $-4.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.45 0.45 1.92 3.80 5.47
Quick Ratio
0.36 0.36 1.49 3.46 5.10
Cash Ratio
0.28 0.28 1.02 1.90 1.71
Solvency Ratio
-0.78 -0.78 -0.82 -0.64 -0.62
Operating Cash Flow Ratio
-0.86 -0.86 -5.00 -3.33 -4.41
Short-Term Operating Cash Flow Coverage
-1.17 -1.17 -37.45 0.00 -37.55
Net Current Asset Value
$ -37.64M$ -37.64M$ -54.94M$ -29.05M$ -16.77M
Leverage Ratios
Debt-to-Assets Ratio
1.42 1.42 1.72 0.96 0.72
Debt-to-Equity Ratio
-1.77 -1.77 -1.48 -4.52 6.52
Debt-to-Capital Ratio
2.31 2.31 3.08 1.28 0.87
Long-Term Debt-to-Capital Ratio
0.00 0.00 5.13 1.37 0.84
Financial Leverage Ratio
-1.24 -1.24 -0.86 -4.69 9.06
Debt Service Coverage Ratio
-0.94 -0.94 -7.38 -5.41 -5.52
Interest Coverage Ratio
-9.30 -9.30 -8.88 -5.66 -7.51
Debt to Market Cap
669.11 2.52 7.04 0.58 0.31
Interest Debt Per Share
21.01 21.01 1.28K 2.07K 2.57K
Net Debt to EBITDA
-0.77 -0.77 -0.89 -0.88 -1.09
Profitability Margins
Gross Profit Margin
-113.58%-113.58%5.23%26.21%-17.37%
EBIT Margin
-621.91%-621.91%-250.70%-155.62%-219.88%
EBITDA Margin
-609.97%-609.97%-246.01%-146.58%-202.48%
Operating Profit Margin
-690.45%-690.45%-242.30%-153.16%-228.11%
Pretax Profit Margin
-696.19%-696.19%-277.98%-175.50%-258.12%
Net Profit Margin
-696.19%-696.19%-277.98%-175.50%-258.12%
Continuous Operations Profit Margin
-696.19%-696.19%-277.98%-175.50%-258.12%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.83%100.83%114.72%114.59%113.16%
Return on Assets (ROA)
-143.91%-143.91%-180.29%-81.34%-59.18%
Return on Equity (ROE)
147.27%178.62%155.13%381.62%-536.31%
Return on Capital Employed (ROCE)
232.56%232.56%-222.75%-87.97%-59.70%
Return on Invested Capital (ROIC)
-230.51%-230.51%-200.41%-85.90%-57.78%
Return on Tangible Assets
-143.91%-143.91%-180.29%-81.34%-59.18%
Earnings Yield
-872123.08%-305.52%-856.11%-60.07%-31.11%
Efficiency Ratios
Receivables Turnover
5.07 5.07 10.31 5.47 3.56
Payables Turnover
10.06 10.06 16.31 7.31 10.34
Inventory Turnover
3.19 3.19 4.86 5.30 5.85
Fixed Asset Turnover
0.79 0.79 1.68 1.94 1.22
Asset Turnover
0.21 0.21 0.65 0.46 0.23
Working Capital Turnover Ratio
-0.66 -0.66 1.06 0.73 17.21
Cash Conversion Cycle
150.27 150.27 88.11 85.77 129.72
Days of Sales Outstanding
72.06 72.06 35.40 66.79 102.65
Days of Inventory Outstanding
114.49 114.49 75.09 68.92 62.37
Days of Payables Outstanding
36.28 36.28 22.38 49.93 35.30
Operating Cycle
186.55 186.55 110.49 135.70 165.02
Cash Flow Ratios
Operating Cash Flow Per Share
-18.44 -18.44 -992.67 -1.22K -1.78K
Free Cash Flow Per Share
-18.52 -18.52 -999.31 -1.24K -1.81K
CapEx Per Share
0.07 0.07 6.65 14.48 33.13
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
-250.71 -250.71 -149.35 -84.51 -53.75
Capital Expenditure Coverage Ratio
-250.71 -250.71 -149.35 -84.51 -53.75
Operating Cash Flow Coverage Ratio
-0.97 -0.97 -0.85 -0.67 -0.76
Operating Cash Flow to Sales Ratio
-6.69 -6.69 -2.27 -1.39 -2.38
Free Cash Flow Yield
-78327.39%-294.85%-703.74%-47.98%-29.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.33 -0.12 -1.66 -3.21
Price-to-Sales (P/S) Ratio
<0.01 2.28 0.32 2.92 8.30
Price-to-Book (P/B) Ratio
>-0.01 -0.58 -0.18 -6.35 17.24
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -0.34 -0.14 -2.08 -3.42
Price-to-Operating Cash Flow Ratio
>-0.01 -0.34 -0.14 -2.11 -3.48
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 <0.01 0.08 0.04
Price-to-Fair Value
>-0.01 -0.58 -0.18 -6.35 17.24
Enterprise Value Multiple
-0.77 -1.14 -1.02 -2.87 -5.19
Enterprise Value
33.87M 50.20M 56.13M 118.05M 190.58M
EV to EBITDA
-0.77 -1.14 -1.02 -2.87 -5.19
EV to Sales
4.71 6.98 2.52 4.21 10.51
EV to Free Cash Flow
-0.70 -1.04 -1.10 -3.00 -4.33
EV to Operating Cash Flow
-0.70 -1.04 -1.11 -3.04 -4.41
Tangible Book Value Per Share
-10.74 -10.74 -783.66 -406.11 359.60
Shareholders’ Equity Per Share
-10.74 -10.74 -783.66 -406.11 359.60
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
2.76 2.76 437.33 883.10 747.14
Net Income Per Share
-19.19 -19.19 -1.22K -1.55K -1.93K
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.12 1.12 1.11 1.13 1.17
Research & Development to Revenue
1.97 1.97 1.16 0.78 0.93
SG&A to Revenue
0.00 0.00 1.37 0.00 0.00
Stock-Based Compensation to Revenue
0.60 0.60 0.29 0.25 0.22
Income Quality
0.96 0.96 0.82 0.79 0.92
Currency in USD